- Home
- GBTG vs CORT Comparison
GBTG vs CORT Comparison
Compare GBTG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GBTG | CORT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GBTG | CORT |
|---|---|---|
| Price | $5.50 | $40.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $10.25 | ★ $114.20 |
| AVG Volume (30 Days) | 1.7M | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.24 | $23.03 |
| Revenue Next Year | $19.98 | $19.76 |
| P/E Ratio | $496.25 | ★ $45.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.03 | $32.99 |
| 52 Week High | $9.00 | $117.33 |
Technical Indicators
Market Signals| Indicator | GBTG | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 32.53 | 40.40 |
| Support Level | $5.03 | $38.00 |
| Resistance Level | $5.72 | $41.92 |
| Average True Range (ATR) | 0.36 | 1.94 |
| MACD | -0.09 | 0.94 |
| Stochastic Oscillator | 23.41 | 30.99 |
Price Performance
Historical ComparisonAbout GBTG Global Business Travel Group Inc.
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.